VIV(VIV)
VIV
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $51.85B | $54.90B | $57.46B | $63.17B |
| Low | $50.97B | $53.40B | $55.22B | $60.71B |
| High | $53.12B | $57.08B | $58.78B | $64.62B |
| EBITDA Avg | $21.95B | $23.24B | $24.33B | $26.74B |
| Low | $21.58B | $22.61B | $23.38B | $25.70B |
| High | $22.49B | $24.16B | $24.88B | $27.36B |
| EBIT Avg | $10.30B | $10.90B | $11.41B | $12.55B |
| Low | $10.12B | $10.61B | $10.97B | $12.06B |
| High | $10.55B | $11.34B | $11.67B | $12.83B |
| Net Income Avg | $6.69B | $8.40B | $9.49B | $14.34B |
| Low | $6.21B | $7.22B | $9.01B | $13.61B |
| High | $6.97B | $9.03B | $9.78B | $14.76B |
| EPS Avg | $4.15 | $5.21 | $5.89 | $8.89 |
| Low | $3.85 | $4.48 | $5.59 | $8.44 |
| High | $4.32 | $5.60 | $6.07 | $9.16 |
| Analysts (Rev / EPS) | 9 / 4 | 8 / 4 | 6 / 3 | 7 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $12.91B | $13.39B | $13.45B | $13.37B | $13.56B | $14.08B | $13.97B | $14.15B |
| Low | $12.82B | $13.30B | $13.36B | $13.28B | $13.47B | $13.98B | $13.87B | $14.05B |
| High | $12.95B | $13.58B | $13.64B | $13.56B | $13.75B | $14.27B | $14.16B | $14.35B |
| EBITDA Avg | $5.47B | $5.67B | $5.69B | $5.66B | $5.74B | $5.96B | $5.91B | $5.99B |
| Low | $5.43B | $5.63B | $5.66B | $5.62B | $5.70B | $5.92B | $5.87B | $5.95B |
| High | $5.48B | $5.75B | $5.77B | $5.74B | $5.82B | $6.04B | $6.00B | $6.07B |
| EBIT Avg | $2.56B | $2.66B | $2.67B | $2.66B | $2.69B | $2.80B | $2.77B | $2.81B |
| Low | $2.55B | $2.64B | $2.65B | $2.64B | $2.68B | $2.78B | $2.76B | $2.79B |
| High | $2.57B | $2.70B | $2.71B | $2.69B | $2.73B | $2.83B | $2.81B | $2.85B |
| Net Income Avg | $1.70B | $2.14B | $1.71B | $1.75B | $1.96B | $2.00B | $1.89B | $2.02B |
| Low | $1.49B | $2.12B | $1.69B | $1.73B | $1.95B | $1.99B | $1.87B | $2.00B |
| High | $1.83B | $2.18B | $1.74B | $1.78B | $2.00B | $2.04B | $1.92B | $2.06B |
| EPS Avg | $1.06 | $1.34 | $1.07 | $1.09 | $1.23 | $1.25 | $1.18 | $1.26 |
| Low | $0.93 | $1.33 | $1.06 | $1.08 | $1.22 | $1.24 | $1.17 | $1.25 |
| High | $1.15 | $1.37 | $1.09 | $1.11 | $1.25 | $1.28 | $1.20 | $1.29 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |